Noninvasive urothelial carcinoma (UC) with glandular differentiation in the absence of infiltrating carcinoma is a rare entity that has not been well characterized. We retrieved 24 cases of noninvasive UC of the bladder with glandular differentiation on biopsy (n = 20) or transurethral resection (n = 4) without an associated invasive component. The cases were identified from the consult files of one of the authors between 1992 and 2008. Mean patient age at diagnosis was 70 years (range: 48 to 87 y) and 75% were male. Half of the cases were pure noninvasive UC with glandular differentiation; half were associated with either carcinoma in situ or high-grade noninvasive papillary carcinoma. The glandular component consisted of 1 or more patterns: papillary (46% of cases), glandular (42%), cribriform (33%), and flat (25%). Mitoses, apoptosis, and necrosis were identified in 83%, 67%, and 17% of the biopsies, respectively. One case was a recent diagnosis, and 5 patients either refused treatment or were lost to follow-up. Of the 18 patients with available follow-up information, 9 (50%) did not develop invasive carcinoma; the remaining 9 (50%) eventually developed an invasive bladder tumor. Of these, 2 were small cell carcinoma, 3 were poorly-differentiated UC (2 of these developed widespread metastases), and 4 were UC, not otherwise specified. In both instances of eventual small cell carcinoma, and in 2 of the 3 cases of poorly-differentiated UC, the initial biopsy consisted of pure noninvasive UC with glandular differentiation without carcinoma in situ or noninvasive papillary carcinoma. Of note, none of the patients in the study developed invasive adenocarcinoma.
A denocarcinomas account for 0.5% to 2% of primary epithelial malignancies of the urinary bladder. 6 Although the histologic characteristics and clinical out-comes in cases of invasive adenocarcinoma of the bladder have been well established, it is unclear how often this invasive lesion is associated with an in situ component. 1, 17 Another glandular lesion seen in the bladder is urothelial carcinoma (UC) with glandular differentiation. There are few studies describing an initial diagnosis of UC with glandular differentiation in the absence of an invasive component. The only 2 previous studies on this rare entity describe only 1 and 10 cases each, the latter study using the terminology of ''in situ adenocarcinoma.'' 2, 14 This study was performed to describe the histology of noninvasive UC with glandular differentiation in further detail to evaluate, with a large number of cases, its morphology and prognosis.
MATERIALS AND METHODS
Noninvasive UC of the bladder with glandular differentiation on biopsy or transurethral resection (TUR) were retrieved from the consult files of one of the authors (J.I.E.) between 1992 and 2008. Lesions were defined as noninvasive glandular lesions characterized by columnar epithelium with cellular atypia. Carcinoma in situ (CIS) with small cystic spaces (with or without mucin) not lined by glandular epithelium (ie, ''gland-like lumina'') were excluded. Noninvasive cancers predominantly composed of micropapillary UC with areas showing focal glandular differentiation were also excluded as these cases are considered micropapillary UCs. 10, 16 The distinction between noninvasive and invasive UC with glandular differentiation was based on analogous criteria used in the diagnosis of malignant glandular lesions in the gastrointestinal tract: (1) noninvasive glands lacked a desmoplastic or associated inflammatory stromal reaction; (2) the base of the lesion was parallel to the basement membrane of the adjacent uninvolved mucosa; (3) single cells and isolated poorly formed glands were absent.
Each of the cases was evaluated for the following histologic features: growth pattern, mitoses, necrosis, apoptosis, inflammation, and associated noninvasive UC. Growth pattern of the glandular component was defined as 1 of 4 patterns: papillary (fibrovascular cores lined by columnar epithelium), glandular (columnar cells making large or small individual glandular spaces), cribriform (columnar cells surrounding small ''sieve-like'' spaces), and flat (columnar cells lining a flat surface). Mitoses, necrosis, and apoptosis were defined as either present or absent. Inflammation was graded as 0 through 3 and categorized as acute, chronic, or mixed. When noninvasive UC was present, the extent of the urothelial component (either CIS or noninvasive papillary UC) was quantified compared with the extent of the UC with glandular differentiation component.
An attempt was made to obtain clinical follow-up on each patient by contacting the patients' urologists through a faxed questionnaire. Each case was evaluated for the following parameters: length of clinical follow-up; postbiopsy treatment modality; results of any additional pathology specimens (eg, cystectomy); presence of metastases; and mortality. Five of the cases were reported previously by the current authors, yet in 3 of the 5 cases we were able to increase the follow-up (Table 1) : case 11, no evidence of disease (NED) at 5 months in prior study to death due to disease at 3 years in this study; case 19, NED at 1 year in prior study to NED at 12 years in this study; case 23, NED at 4 years in prior study to NED at 12 years in this study. 2 Cases 18 and 20 have the same follow-up as previously reported. 
RESULTS
We identified 24 cases of noninvasive UC with glandular differentiation on biopsy (n = 20) or TUR (n = 4) without an associated invasive component. The mean patient age at diagnosis was 70 years (range: 48 to 87 y) and 75% were male. The histologic and clinical findings are listed in the Table 1 . The contributing pathologist recognized noninvasive UC with glandular differentiation in 3 cases (13%); other preliminary diagnoses were ''atypical glandular lesion'' (17%), noninvasive papillary UC (21%), CIS (8%), cystitis glandularis with atypia (4%), nephrogenic adenoma (4%), and villous adenoma (4%).
The size of the lesions (measured microscopically) ranged from 1 to 9 mm, with an average of 3.2 mm. Half of the cases were pure noninvasive UC with glandular differentiation with the remaining half associated with CIS (33%) (Figs. 1A-C), high-grade noninvasive papillary UC (29%), or noninvasive micropapillary UC (4%). The noninvasive UC with glandular differentiation component consisted of 1 or more patterns: papillary (46% of cases) (Figs. 1D-F, 2), glandular (42%) ( Fig. 3 ), cribriform (33%) (Figs. 4, 5), and flat (25%) ( Fig. 6 ). Only 2 cases had purely flat morphology. In some cases, there were cytologic similarities between the cells with glandular differentiation and the cells of UC (Figs. 1C, E, 6B), whereas other cases resembled adenocarcinoma unrelated to UC (Fig. 4B) . Mitoses, apoptosis, and necrosis were identified in 83%, 67%, and 17% of the biopsies, respectively (Figs. 7, 8) . Three of the 4 cases with necrosis had only focal necrosis. Two-third of the cases had a significant inflammatory infiltrate (scored as 2 or 3); 94% of those consisted of chronic inflammatory cells alone or in combination with acute inflammation.
One case was a recent diagnosis, and 5 patients either refused treatment or were lost to follow up (Table 1) . Of the 18 patients with available follow-up information, 9 (50%) did not develop invasive carcinoma and were treated with bacille Calmette-Gue´rin, cystectomy, or TUR (1 patient refused treatment and did not develop invasive disease). The remaining 9 (50%) eventually developed an invasive bladder tumor regardless of treatment modality. Of those with invasion, 2 were small cell carcinoma, 3 were poorly-differentiated UC (2 of these developed widespread metastases), and 4 were UC, not otherwise specified. In both instances of eventual small cell carcinoma, and in 2 of the 3 cases of poorlydifferentiated UC, the initial biopsy consisted of pure noninvasive UC with glandular differentiation without CIS or noninvasive papillary carcinoma. Five of the 9 (56%) patients who developed invasive disease (28% of all patients with available follow-up) died of bladder cancer. Of note, none of the patients in the study developed invasive adenocarcinoma.
DISCUSSION
Before this study, there has been only 1 series describing noninvasive UC of the bladder with glandular differentiation and, before that, 1 case report. 2, 14 In the prior series cowritten by 1 of the current authors, the term in situ adenocarcinoma was used in an analogous definition to noninvasive malignant glandular lesions found in other sites. This term is controversial for the lesions described herein as some experts consider that by definition in situ adenocarcinoma should be restricted for a lesion originating from glandular cells (ie, in the bladder from cystitis glandularis). The coexistence of CIS and/or high-grade noninvasive UC favors that the lesions in this study represent divergent differentiation of UC. Although none of our cases subsequently developed invasive adenocarcinoma, but rather developed UC also supports that these lesions are noninvasive UC with divergent glandular differentiation.
The prior series examined 19 cases of noninvasive UC with glandular differentiation. However, only 10 of the cases lacked invasive tumor at the time of initial diagnosis (ie, the remaining 9 cases were associated with invasive adenocarcinoma, invasive UC, or small cell carcinoma). Although that study focused on the relationship of noninvasive UC with glandular differentiation to other in situ and invasive lesions at the time of diagnosis, we have attempted to determine the consequences of an initial diagnosis of noninvasive UC with glandular differentiation in the absence of infiltrating carcinoma. Furthermore, we have explored the histologic features and diagnostic criteria of noninvasive UC with glandular differentiation.
As noninvasive UC with glandular differentiation can have differing histologic patterns, there are several entities that enter into the differential diagnosis. One lesion that needs to be distinguished from the papillary pattern of noninvasive UC with glandular differentiation is villous adenoma of the bladder. 3 One distinction is that villous adenoma is typically a large sessile papillary tumor, whereas papillary noninvasive UC with glandular differentiation does not result in a sizable mass lesion. The papillae within noninvasive UC with glandular differentiation further lack the characteristic long finger-like fronds, which is typical of a villous adenoma. The papillary pattern of noninvasive UC with glandular differentiation is also often only a focal pattern admixed with other patterns of noninvasive UC with glandular differentiation and with CIS and/or high-grade papillary UC, whereas villous adenomas are predominantly or purely villous and do not have an association with UC. In some cases of UC with glandular differentiation, the cytologic similarities between the cells with glandular differentiation and the cells of UC can further help to rule out non-UC related lesions like villous adenoma.
Both the glandular and cribriform variants of noninvasive UC with glandular differentiation can be confused with UC with gland-like lumina, which consists of small cystic spaces with or without mucin. 13 These cystic spaces are lined by urothelial cells as opposed to noninvasive UC with glandular differentiation which are lined by columnar cells with apical cytoplasm. There is no prognostic significance to gland-like lumina, which can be present in CIS, noninvasive papillary UC, and invasive UC. The flat variant of noninvasive UC with glandular differentiation can look at low power very similar to CIS, but the pseudostratified columnar cells will reveal themselves upon closer inspection. A contributing factor to the underrecognition of noninvasive UC with glandular differentiation is that pathologists might not think of the diagnosis owing to its rarity. CIS is considered the typical diagnosis for a flat lesion with atypia. Similarly, papillary and cribriform patterns of noninvasive UC with glandular differentiation may be underdiagnosed as more common reactive proliferations such as cystitis glandularis. 18 Another contributing factor to the difficulty in recognizing noninvasive UC with glandular differentiation compared with CIS and cystitis glandularis is that noninvasive UC with glandular differentiation need not be as atypical as adenocarcinoma in situ in other sites, such as the gastrointestinal tract. Lesions that would qualify as noninvasive UC with glandular differentiation in the bladder would, in some instances, be considered glandular dysplasia in other organs. Support for the somewhat more relaxed criteria for noninvasive UC with glandular differentiation is its often association with CIS and its high risk of progressing to invasive carcinoma. In cases of noninvasive UC with glandular differentiation with less severe cytologic atypia, the presence of mitoses, seen in most of our cases (83%) may be helpful in distinguishing this lesion from benign mimickers. One would not expect to see mitotic activity in cystitis glandularis unless accompanied by acute inflammation. 9 The majority of our cases of noninvasive UC with glandular differentiation were associated with chronic inflammation, yet uncommonly with an acute inflammatory infiltrate.
None of the patients in our series developed invasive adenocarcinoma. However, 50% eventually developed invasive bladder cancers. This is a higher rate of progression than the 28%, 34%, or 36% that have been reported after de novo CIS. 11, 15, 20 Of the 9 patients in our study that did develop invasive tumors, 2 had small cell carcinoma and 2 had poorly-differentiated UCs that widely metastasized. 7, 12 The remaining 5 had invasive UCs. That noninvasive UC with glandular differentiation is associated with these high-grade invasive tumors indicates that this intraepithelial lesion should be 
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Am J Surg Pathol Volume 33, Number 8, August 2009 considered at least and possibly more worrisome than CIS. Although only 2 of our cases (11%) were associated with small cell carcinoma, this is more than what would be expected based on chance alone; the incidence of primary small cell carcinoma of the bladder is 0.5 to 0.7%. 8 A previous study noted that 26% of noninvasive UC with glandular differentiation were associated with concurrent or subsequent invasive small cell carcinoma, 2 which further supports that this association is biologic and not artifactual. Although that study found an increased incidence of concurrent or subsequent invasive micropapillary carcinoma (21%), only 1 of the patients in our study was diagnosed as such.
It is not surprising that half of the cases of noninvasive UC with glandular differentiation described herein were associated with either CIS or noninvasive papillary urothelial neoplasia, as it has been well-documented that glandular divergent differentiation is well recognized in invasive bladder cancer. 4, 5, 19 The patients in our study with isolated noninvasive UC with glandular differentiation had a similar mortality rate to those who also had CIS or papillary UC (27% and 33%, respectively). However, the incidence of either small cell carcinoma or poorly-differentiated UC was higher in the cohort with pure noninvasive UC with glandular differentiation (36%) than in the patients with mixed (17%) lesions, albeit based on small numbers. As with CIS and noninvasive papillary urothelial neoplasms of the bladder, noninvasive UC with glandular differentiation tends to arise in older patients (average age of 70 y) and more commonly in men (75%). Patients who developed invasive disease tended to be older (average age of 74 y) than those who did not (average age of 66 y).
In summary, noninvasive UC with glandular differentiation of the bladder is a rare lesion that is associated with an increased risk of developing highgrade invasive tumor. Although in situ and invasive adenocarcinoma of the bladder commonly coexist, the finding of noninvasive UC with glandular differentiation does not seem to have an association with the subsequent development of invasive adenocarcinoma. Furthermore, there seems to be a correlation between these noninvasive lesions and eventual high-grade, prognostically poor invasive bladder carcinomas such as small cell carcinoma and poorly-differentiated UC. It is important for pathologists to recognize noninvasive UC with glandular differentiation, as patients with this diagnosis should be followed at least as closely as those patients with CIS. Further recognition of noninvasive UC with glandular differentiation will lead to its increase study and reporting, which will increase our understanding of its tumor biology.
